I agree that this site is using cookies. You can find further informations here.
X
Pulsoni, A.
323  results:
Search for persons X
?
1

The impact of spleen metabolic tumor volume on total metabo..:

Guerra, L. ; Chauvie, S. ; Marcheselli, L....
Hematological Oncology.  41 (2023)  S2 - p. 339-340 , 2023
Link: https://doi.org/10.1002/..
 
?
2

MARGINAL ZONE LYMPHOMA INTERNATIONAL PROGNOSTIC INDEX (MZL‐..:

Luminari, S. ; Bommier, C. ; Fabbri, N....
Hematological Oncology.  41 (2023)  S2 - p. 102-103 , 2023
Link: https://doi.org/10.1002/..
 
?
3

COMBINED USE OF MINIMAL RESIDUAL DISEASE MONITORING AND FDG..:

Ferrero, S. ; Assanto, G. M. ; Durmo, R....
Hematological Oncology.  41 (2023)  S2 - p. 183-185 , 2023
Link: https://doi.org/10.1002/..
 
?
4

Early clearance of hairy cell leukaemia in the bone marrow ..:

Ligia, S. ; Passucci, M. ; Assanto, G. M....
British Journal of Haematology.  204 (2023)  4 - p. 1288-1292 , 2023
Link: https://doi.org/10.1111/..
 
?
5

THE IELSG39 TRIAL: EFFICACY OF FIRST‐LINE CHLAMYDIA PSITTAC..:

Ferreri, A. J. M. ; Sassone, M. C. ; Cangi, M. G....
Hematological Oncology.  41 (2023)  S2 - p. 106-107 , 2023
Link: https://doi.org/10.1002/..
 
?
6

FRONTLINE INTENSIFIED ABVD DEMONSTRATES SUPERIOR EFFICACY T..:

Pinto, A. ; Corazzelli, G. ; Evangelista, A....
Hematological Oncology.  41 (2023)  S2 - p. 31-33 , 2023
Link: https://doi.org/10.1002/..
 
?
7

Prognostic value of the end of induction PET in patients wi..:

Guerra, L. ; Bergesio, F. ; Fallanca, F....
Hematological Oncology.  41 (2023)  S2 - p. 378-378 , 2023
Link: https://doi.org/10.1002/..
 
?
8

UPDATED RESULTS OF THE FIL "MIRO" STUDY, A MULTICENTER PHAS..:

Pulsoni, A. ; Tosti, M. E. ; Ferrero, S....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
9

BRENTUXIMAB VEDOTIN CONSOLIDATION AFTER AUTOLOGOUS STEM CEL..:

Massaro, F. ; Pavone, V. ; Stefani, P. M....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
10

FAVOURABLE PROGNOSTIC ROLE OF HIGH BASAL MAXIMAL STANDARDIZ..:

Assanto, G. M. ; Ciotti, G. ; Brescini, M....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
11

THE ROLE OF END OF TREATMENT PET CT EVALUATED BY DEAUVILLE ..:

Assanto, G. M. ; Agrippino, R. ; Lapietra, G....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
12

RESPONSE ADAPTED POST INDUCTION THERAPY IN FOLLICULAR LYMPH..:

Luminari, S. ; Galimberti, S. ; Versari, A....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
13

EARLY METABOLIC RESPONSE IN FOLLICULAR LYMPHOMA: A SUBSET A..:

Luminari, S. ; Guerra, L. ; Durmo, R....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
14

PHASE II TRIAL OF RITUXIMAB PLUS CHLORAMBUCIL FOLLOWED BY A..:

Pirosa, M. C. ; Orsucci, L. ; Feugier, P....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
15

DIRECT‐ACTING ANTIVIRALS AS PRIMARY TREATMENT FOR HCV‐ASSOC..:

Merli, M. ; Rattotti, S. ; Spina, M....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
1-15